Mitoxantrone (N) vs. 5-fluorouracil/epirubicin/cyclophosphamide (FEC) as first line therapy in high-risk metastatic breast cancer

被引：0
|
作者：
vonMinckwitz, G
Heidemann, E
Souchon, R
Samonigg, H
Hirschmann, WD
Bodenstein, H
Schindler, A
Schulze, M
Clemens, H
Konig, M
Scharl, A
Fischer, JT
Kaufmann, M
机构：
[1] UNIV FRANKFURT,FRAUENKLIN,D-6000 FRANKFURT,GERMANY
[2] DIAKONISSENKRANKENHAUS STUTTGART,STUTTGART,GERMANY
[3] KH HAGEN,HAGEN,GERMANY
[4] UNIV KLIN GRAZ,GRAZ,AUSTRIA
[5] STADT KLINIKEN KASSEL,KASSEL,GERMANY
[6] KH MINDEN,MINDEN,GERMANY
[7] UNIV ESSEN GESAMTHSCH,FRAUENKLIN,ESSEN,GERMANY
[8] KH ZITTAU,ZITTAU,GERMANY
[9] UNIV TUBINGEN,KINDERKLIN,D-7400 TUBINGEN,GERMANY
[10] UNIV TUBINGEN,MED KLIN,D-7400 TUBINGEN,GERMANY
[11] UNIV COLOGNE,FRAUENKLIN,COLOGNE,GERMANY
[12] STADT KLINIKEN KARLSRUHE,KARLSRUHE,GERMANY
来源：
EUROPEAN JOURNAL OF CANCER | 1997年 / 33卷
关键词：
D O I：
暂无
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
引用
收藏
页码：646 / 646
页数：2
相关论文
共 50 条
  • [21] Adjuvant therapy of primary breast cancer with doxorubicin vs. pirarubicin in combination with cyclophosphamide and 5-fluorouracil (FBC vs. FPC)
    Budisic, Z
    Podolski, P
    Markulin-Grgic, L
    Santek, F
    Kosovel, E
    EUROPEAN JOURNAL OF CANCER, 1998, 34 : S36 - S37
  • [22] Phase III trial of cyclophosphamide, epirubicin, fluorouracil (CEF) versus cyclophosphamide, mitoxantrone, fluorouracil (CNF) in women with metastatic breast cancer
    E. Esteban
    A.J. Lacave
    J.L. Fernández
    N. Corral
    J.M. Buesa
    E. Estrada
    I. Palacio
    J.M. Vieitez
    I. Muñiz
    E. Alvarez
    Breast Cancer Research and Treatment, 1999, 58 : 141 - 150
  • [23] Phase III trial of cyclophosphamide, epirubicin, fluorouracil (CEF) versus cyclophosphamide, mitoxantrone, fluorouracil (CNF) in women with metastatic breast cancer
    Esteban, E
    Lacave, AJ
    Fernández, JL
    Corral, N
    Buesa, JM
    Estrada, E
    Palacio, I
    Vieitez, JM
    Muñiz, I
    Alvarez, E
    BREAST CANCER RESEARCH AND TREATMENT, 1999, 58 (02) : 141 - 150
  • [24] FOLINIC ACID, 5-FLUOROURACIL BOLUS AND INFUSION AND MITOXANTRONE WITH OR WITHOUT CYCLOPHOSPHAMIDE IN METASTATIC BREAST-CANCER
    LOUVET, C
    DEGRAMONT, A
    DEMUYNCK, B
    BEERBLOCK, K
    VARETTE, C
    SOUBRANE, D
    MARPEAU, L
    PIGNE, A
    GUILLOT, T
    KRULIK, M
    EUROPEAN JOURNAL OF CANCER, 1993, 29A (13) : 1835 - 1838
  • [25] Prospective randomized study of cyclophosphamide, epirubicin, and 5-fluorouracil versus cyclophosphamide, adriamycin, and 5-fluorouracil in advanced or recurrent breast cancer
    Kobayashi T.
    Koyama H.
    Oka T.
    Yasumura T.
    Kan N.
    Takatsuka Y.
    Noguchi M.
    Morimoto K.
    Suzuki T.
    Tobe T.
    Mori T.
    Breast Cancer, 1999, 6 (1) : 37 - 42
  • [26] CYCLOPHOSPHAMIDE, MITOXANTRONE, 5-FLUOROURACIL AND PREDNISOLONE IN THE TREATMENT OF FEMALE-PATIENTS WITH METASTATIC BREAST-CANCER
    KUHRER, I
    LUDWIG, H
    SCHEITHAUER, W
    ZIELINSKI, C
    ONKOLOGIE, 1987, 10 (05): : 276 - 276
  • [27] Epirubicin/Docetaxel (ET) versus 5FU/Epirubicin/Cyclophosphamide (FEC) combinations as first line chemotherapy in patients with metastatic breast cancer [MBC].
    Bonneterre, JM
    Dieras, V
    Tubiana-Hulin, M
    Bougnoux, P
    Bonneterre, MEA
    Bendahmane, B
    BREAST CANCER RESEARCH AND TREATMENT, 2001, 69 (03) : 215 - 215
  • [28] COMPARISON OF CYCLOPHOSPHAMIDE, ADRIAMYCIN, AND 5-FLUOROURACIL VERSUS CYCLOPHOSPHAMIDE, METHOTREXATE, AND 5-FLUOROURACIL IN METASTATIC BREAST-CANCER
    BULL, J
    TORMEY, D
    FALKSON, G
    BLOM, J
    PERLIN, E
    CARBONE, P
    PROCEEDINGS OF THE AMERICAN ASSOCIATION FOR CANCER RESEARCH, 1975, 16 (MAR): : 246 - 246
  • [29] Metformin synergizes 5-fluorouracil, epirubicin, and cyclophosphamide (FEC) sensitivity in breast cancer stem cells and non-stem breast cancer cells
    Soo, Sian Siu
    Ng, Char Hong
    Malik, Rozita Abdul
    Teh, Yew Ching
    Tan, Boon Shing
    Ho, Gwo Fuang
    See, Mee Hoong
    Taib, Nur Aishah Mohd
    Yip, Cheng Har
    Teo, Soo Hwang
    Leong, Chee Onn
    CANCER RESEARCH, 2014, 74 (19)
  • [30] Combined 5-fluorouracil infusion with fractionated epirubicin and cyclophosphamide in advanced breast cancer
    Recchia, F
    De Filippis, S
    Rosselli, M
    Saggio, G
    Pompili, P
    Piccinini, M
    Rea, S
    AMERICAN JOURNAL OF CLINICAL ONCOLOGY-CANCER CLINICAL TRIALS, 2001, 24 (04): : 392 - 396
12345